000 | 01071 a2200289 4500 | ||
---|---|---|---|
005 | 20250513061105.0 | ||
264 | 0 | _c19930219 | |
008 | 199302s 0 0 eng d | ||
022 | _a0140-6736 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGore, S M | |
245 | 0 | 0 |
_aOSIRIS trial. _h[electronic resource] |
260 |
_bLancet (London, England) _cJan 1993 |
||
300 |
_a172; author reply 173-4 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Letter; Randomized Controlled Trial; Comment | ||
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 |
_aFatty Alcohols _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aPhosphorylcholine |
650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
650 | 0 | 4 |
_aPulmonary Surfactants _xadministration & dosage |
650 | 0 | 4 |
_aRespiratory Distress Syndrome, Newborn _xdrug therapy |
773 | 0 |
_tLancet (London, England) _gvol. 341 _gno. 8838 _gp. 172; author reply 173-4 |
|
999 |
_c8093086 _d8093086 |